Event agenda

Workshop 1: Recruitment for vaccine trials

Coffee Break

Workshop 2: Impact of the European Clinical Trial Regulation

Welcome by Flanders Vaccine

Transforming vaccinology in the era of artificial intelligence - Prof. Rino Rappuoli, Fondazione Biotecnopolo di Siena, Siena, Italy

During the last 30 years the vaccine field has been transformed by Reverse Vaccinology, Structural Vaccinology, Synthetic Biology, and Artificial Intelligence (AI).

The use of Artificial Intelligence and Machine Learning (AI/ML) in the development of mRNA vaccines - Fernando Ulloa Montoya, Sanofi

AI&ML and mechanistic modeling allow us to tackle the complex combinatorial problem of mRNA sequence, lipid nano-particles design and process development to optimize critical quality attributes and immune response of mRNA vaccines

Revealing vaccine-induced T-cell responses using Artificial Intelligence – Pieter Meysman, Antwerp University

The vaccine-mediated immune response is a complex system mediated by a combination of different cell types. In this talk, I will discuss how we are using artificial intelligence to help us understand how and why people respond to vaccines the way they do.

Coffee Break

Pitch Session: Innovation pitches - Call for abstracts

Lunch & Networking

Immune Aging in Health and Disease – Prof. Helena Slaets, Hasselt University

With increasing age, the ability of the immune system to clear pathogens and malignant cells decreases. This talk discusses the mechanisms of immune aging as well as possible therapeutic interventions.

Biomarkers of vaccine response to improve vaccination strategies in vulnerable groups – Prof. Debbie van Baarle, UMC, Groningen

The use of immune cell phenotyping to identify individuals with decreased vaccination response within a clinical vaccination study in which we studied the immune response to 3 different vaccines.

Health Economics of Vaccines; conventional approaches and broader impacts illustrated with respiratory infection- Prof. Maarten Postma, University of Groningen

Health Economics of Vaccines

Adult Immunization Board: A platform to provide multidisciplinary guidelines for the implementation and optimization of adult immunization in Europe – Jade Pattyn, Antwerp University

The Adult Immunization Board (AIB) is established with the aim of contributing to the reduction of mortality and morbidity from vaccine-preventable infections and diseases in European adults.

Coffee Break

Panel discussion: The future of Immunotherapy & Vaccines R&D

Pitch Award & Closing Word

Reception & Networking